All faculty and planners participating in continuing education activities sponsored by Partners for Advancing Clinical Education (PACE) are required to disclose all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PACE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Brian W. Carlin, MD: consultant/advisor/speaker: Aerogen, Monaghan, Theravance, Vitaris.
Samuel Louie, MD: consultant/advisor/speaker: AstraZeneca, Boehringer Ingelheim, Genentech, GSK, Regeneron, Sanofi.
Corinne R. Young, MSN, FNP-C, FCCP: consultant/advisor/speaker: AstraZeneca, Griffols.
The planners and content peer reviewers from Partners for Advancing Clinical Education and Practicing Clinicians Exchange, do not have any relevant financial relationships to disclose.